Receptor Life Sciences is a pharmaceutical company that applies FDA-approved drug-delivery technologies to develop innovative therapies to address central nervous system disorders that …

Olfactive Biosolutions has developed world-leading receptor technology and expertise in both ectopic receptors in the gut, lungs, skin, heart, blood and elsewhere, and olfactory and taste …

Fusion connects alpha particle emitting isotopes to various targeting molecules in order to selectively deliver the alpha emitting payloads to tumors. Fusion's lead program, FPI-1434 …

Established in 2008, Adaptimmune LLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary T-cell receptor platform in the …

Unlocking the Potential of Sigma Proteins: Sigma proteins, a unique evolutionary isolate distinct from any other human proteins, represent the pinnacle of protein evolution. As the unique …

The biological activities of TPCs are transduced through a novel tissue protective cytokine receptor identified by Warren scientists. Tissue Protective Cytokines may have the potential to …

Vicore Pharma is an innovative clinical-stage pharmaceutical company focused on developing life-changing treatments targeting diseases where the AT2 (angiotensin II type 2) receptor plays a …

Akshaya's intellectual property-protected Chimigen® Platform has been used to develop a portfolio of dendritic cell receptor-targeted chimeric molecules which have therapeutic as well …

Popular Searches Arvinas Inc Arvinas Arvinas LLC Arvinas Androgen Receptor Inc Karos Pharmaceuticals

In addition, it develops CORT125134 for the treatment of patients with Cushings syndrome and solid-tumor cancers; and CLIA-validated assay to measure expression of the gene FKBP5, …